Developer docs
API playgroundTry for free, no card

Search company profiles

Hormone Therapeutics

Full company profile

uuid0008qor

Namestring
Hormone Therapeutics
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Hormone Therapeutics is a private, Dallas-based telemedicine company founded in 2014 that operates a national platform for health optimization. Its service model combines in-home diagnostic testing with personalized therapeutics, targeting consumers seeking hormone-related and broader wellness interventions without traditional in-clinic visits. The company runs as a for-profit entity with a small operating team in the 11-50 employee range, and its only disclosed institutional capital event is an early-stage round from StartUp Health dated April 2016; no subsequent funding, valuation, or revenue figures are publicly available.

The underlying offering appears to be a direct-to-consumer telehealth funnel: patients receive at-home test kits, results are interpreted by clinicians, and personalized therapy plans (likely including prescription and compounded hormone products) are delivered remotely. Distribution is implied to be online/DTC, and the company self-describes as serving a national footprint, consistent with multi-state telehealth operations. Beyond this functional description, technical architecture, proprietary protocols, pricing structure, customer acquisition channels, regulatory licensure footprint, and partnership network are not documented in available sources — the company website returned only a verification/loading screen at time of capture, and third-party coverage is absent.

Leadership is anchored by Hunter Howard as President. Given the absence of disclosed revenue, headcount trend, or follow-on capital, the company's current scale, growth velocity, and unit economics cannot be triangulated from public data. The investment-relevant signal set is therefore limited to the firmographic profile, the 2016 StartUp Health affiliation, and the stated telemedicine-plus-lab-testing business model.

Short descriptiontext

Hormone Therapeutics is a private, Dallas-based telemedicine company founded in 2014 that operates a national platform combining in-home diagnostic testing with personalized hormone and wellness therapeutics for direct-to-consumer patients across the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
telemedicine services, hormone therapy, at-home testing, personalized therapeutics, health optimization
Industry1 code
PRIMARYHLALAGAD
Endocrinology & Diabetes Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code2 codes
  • Home Health Care Services62161
  • Home Health Care Services6216
SIC code3 codes
  • Services-Home Health Care Services8082
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
Product category
Telemedicine Hormone Therapy
Social media profiles2 records
Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Hormone Therapeutics operates a national telemedicine platform focused on health optimization. The company delivers personalized hormone therapeutics supported by in-home testing, enabling patients nationwide to access hormone-related consultations and treatment plans remotely.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Hormone Therapy Telemedicine Program
CategoryTelemedicine Healthcare Services
2In-Home Hormone Testing
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hormone Therapeutics

Telemedicine Hormone Therapyhormonetherapeutics.com

Hormone Therapeutics is a private, Dallas-based telemedicine company founded in 2014 that operates a national platform combining in-home diagnostic testing with personalized hormone and wellness therapeutics for direct-to-consumer patients across the United States.

What Hormone Therapeutics does

Hormone Therapeutics is a private, Dallas-based telemedicine company founded in 2014 that operates a national platform for health optimization. Its service model combines in-home diagnostic testing with personalized therapeutics, targeting consumers seeking hormone-related and broader wellness interventions without traditional in-clinic visits. The company runs as a for-profit entity with a small operating team in the 11-50 employee range, and its only disclosed institutional capital event is an early-stage round from StartUp Health dated April 2016; no subsequent funding, valuation, or revenue figures are publicly available.

The underlying offering appears to be a direct-to-consumer telehealth funnel: patients receive at-home test kits, results are interpreted by clinicians, and personalized therapy plans (likely including prescription and compounded hormone products) are delivered remotely. Distribution is implied to be online/DTC, and the company self-describes as serving a national footprint, consistent with multi-state telehealth operations. Beyond this functional description, technical architecture, proprietary protocols, pricing structure, customer acquisition channels, regulatory licensure footprint, and partnership network are not documented in available sources — the company website returned only a verification/loading screen at time of capture, and third-party coverage is absent.

Leadership is anchored by Hunter Howard as President. Given the absence of disclosed revenue, headcount trend, or follow-on capital, the company's current scale, growth velocity, and unit economics cannot be triangulated from public data. The investment-relevant signal set is therefore limited to the firmographic profile, the 2016 StartUp Health affiliation, and the stated telemedicine-plus-lab-testing business model.

Hormone Therapeutics firmographics

Firmographics
Name
Hormone Therapeutics
Website
https://hormonetherapeutics.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Hormone Therapeutics is a private, Dallas-based telemedicine company founded in 2014 that operates a national platform combining in-home diagnostic testing with personalized hormone and wellness therapeutics for direct-to-consumer patients across the United States.
Ownership category
akta.pro rank

Hormone Therapeutics industry classification

Industry
Product category
Telemedicine Hormone Therapy
NAICS
Home Health Care Services (62161), Home Health Care Services (6216)
SIC
Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
akta.pro industry
PRIMARYHLALAGAD
Endocrinology & Diabetes Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Telemedicine services
  • Hormone therapy
  • At-home testing
  • Personalized therapeutics
  • Health optimization

Where Hormone Therapeutics is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Markets served

Hormone Therapeutics business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Hormone Therapeutics product offering

Product offering

Core offering

Hormone Therapeutics operates a national telemedicine platform focused on health optimization. The company delivers personalized hormone therapeutics supported by in-home testing, enabling patients nationwide to access hormone-related consultations and treatment plans remotely.

Differentiator

Problem solved

Functional benefit

Products and services

  • Hormone Therapy Telemedicine Program
  • In-Home Hormone Testing

Companies that use Hormone Therapeutics

Customer profile

Ideal customer profiles1 record

Hormone Therapeutics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Hormone Therapeutics partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Hormone Therapeutics competitors and assessment

Company assessment

Market position

Strengths3 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Hormone Therapeutics social profiles

Digital presence

Hormone Therapeutics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hormone Therapeutics leadership team

Management profile

Number of profiles

Profiles1 record

Hormone Therapeutics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hormone Therapeutics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hormone Therapeutics

What does Hormone Therapeutics do?

Hormone Therapeutics operates a national telemedicine platform focused on health optimization. The company delivers personalized hormone therapeutics supported by in-home testing, enabling patients nationwide to access hormone-related consultations and treatment plans remotely.

Is Hormone Therapeutics a public or private company?

Hormone Therapeutics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Hormone Therapeutics founded?

Hormone Therapeutics was founded in 2014. It employs 11 to 50 people.

Where is Hormone Therapeutics based?

Hormone Therapeutics is headquartered in Dallas, United States, in the North America region.

Does Hormone Therapeutics have an API?

No public API is recorded for Hormone Therapeutics.

What industry is Hormone Therapeutics in?

Hormone Therapeutics's product category is Telemedicine Hormone Therapy. Its primary akta.pro industry code is HLALAGAD, Endocrinology & Diabetes Telemedicine Platforms. Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Houston ChronicleTexas resident shares personal journey of testing positive for coronavirusHunter Howard, a 50-year-old Dallas resident, tested positive for COVID-19 after a flight from Aspen and recovered after 14 days. He now has lingering taste and smell issues, nausea, and intestinal problems. He advises following social guidelines and shelter-in-place to slow transmission.PR NewswireSilicon Valley Boomer Venture Summit Announces Business Plan Competition Finalists, Keynote Speakers and Boot Camp Sessions for 2017 EventThe Silicon Valley Boomer Venture Summit announced six finalists for its $10,000 Business Plan Competition, to be judged on July 20, 2017 in Berkeley, CA. The finalists—BaroStitch, Carpadien, Geneticure, Hormone Therapeutics, PhysioCue, and Quikiks—are all startups focused on longevity, aging, and healthcare solutions for older adults. The event, organized by Mary Furlong and Associates and The Business of Aging, features judges from AARP, DCM Ventures, UnitedHealthcare, B Capital Group, Viant Group, and Pfizer Consumer Healthcare, along with keynote speakers discussing aging demographics in America and China.PR NewswireHormone Therapeutics Puts Testosterone 'Under the Hood' of the #49 NASCAR Truck in DaytonaHormone Therapeutics sponsored driver Timmy Hill's #49 NASCAR Truck at Daytona, where the team finished 14th after a last-lap incident. The company utilized the high-profile racing event to promote its testosterone replacement therapy services to male demographics.